Influence of Valve Type and Antiplatelet Regimen on Platelet Reactivity After TAVI: Subanalysis of the REAC-TAVI Trial

Trejo-Velasco, B; Cruz-Gonzalez, I; Tello-Montoliu, A; Baz-Alonso, JA; Salvadores, PJ; Moreno, R; Romaguera, R; Molina-Navarro, E; Paredes-Galan, E; De-Miguel-Castro, A; Bastos-Fernandez, G; Ortiz-Saez, A; Fernandez-Barbeira, S; Iniguez-Romo, A; Jimenez-Diaz, VA

Jimenez-Diaz, VA (corresponding author), CIBER CV, Network Res Ctr Cardiovasc Dis, Madrid, Spain.; Jimenez-Diaz, VA (corresponding author), Univ Hosp Vigo, Hosp Alvaro Cunqueiro, Cardiol Dept, Estr Clara Campoamor 341, Vigo 36312, Spain.; Jimenez-Diaz, VA (corresponding author), Univ Hosp Vigo, Hosp Alvaro Cunqueiro, Cardiovasc Res Unit, Estr Clara Campoamor 341, Vigo 36312, Spain.

JOURNAL OF INVASIVE CARDIOLOGY, 2020; 32 (12): 446

Abstract

Objectives. Ticagrelor has proven more effective than clopidogrel at attaining a maintained suppression of high platelet reactivity (HPR) in aortic st......

Full Text Link